Skip navigation
Skip navigation

Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A

Hanna, Amy; Lam, Alex; Tham, Steffi; Dulhunty, Angela; Beard, Nicole


The use of anthracycline chemotherapeutic drugs is restricted owing to potentially fatal cardiotoxic side effects. It has been hypothesized that anthracycline metabolites have a primary role in this cardiac dysfunction; however, information on themolecular interactions of these compounds in the heart is scarce. Here we provide novel evidence that doxorubicin and its metabolite, doxorubicinol, bind to the cardiac ryanodine receptor (RyR2) and to the sarco/endoplasmic reticulumCa2+ATPase...[Show more]

CollectionsANU Research Publications
Date published: 2014
Type: Journal article
Source: Molecular Pharmacology
DOI: 10.1124/mol.114.093849


File Description SizeFormat Image
01_Hanna_Adverse_Effects_of_Doxorubicin_2014.pdf1.06 MBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator